Immunization, Hib3 in Australia
Australia: Immunization, Hib3 was 93.0% in 2024. ▲ Rising
Immunization, Hib3 in Australia, 1997–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Australia is 93.0%, measured in 2024.
Compared with earlier readings it is down 1.1% on the previous year and up 2.2% over ten years.
Over the whole period, immunization, hib3 in Australia peaked at 95.0% in 2001 and was at its lowest, 77.0%, in 1997.
That places Australia 78th out of 191 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 28 years of available data.
Immunization, Hib3 in Australia, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1997 | 77.0% | — |
| 1998 | 82.0% | +6.5% |
| 1999 | 87.0% | +6.1% |
| 2000 | 90.0% | +3.4% |
| 2001 | 95.0% | +5.6% |
| 2002 | 95.0% | +0.0% |
| 2003 | 95.0% | +0.0% |
| 2004 | 95.0% | +0.0% |
| 2005 | 94.0% | -1.1% |
| 2006 | 95.0% | +1.1% |
| 2007 | 94.0% | -1.1% |
| 2008 | 94.0% | +0.0% |
| 2009 | 94.0% | +0.0% |
| 2010 | 92.0% | -2.1% |
| 2011 | 92.0% | +0.0% |
| 2012 | 92.0% | +0.0% |
| 2013 | 91.0% | -1.1% |
| 2014 | 91.0% | +0.0% |
| 2015 | 93.0% | +2.2% |
| 2016 | 94.0% | +1.1% |
| 2017 | 95.0% | +1.1% |
| 2018 | 94.0% | -1.1% |
| 2019 | 95.0% | +1.1% |
| 2020 | 95.0% | +0.0% |
| 2021 | 95.0% | +0.0% |
| 2022 | 94.0% | -1.1% |
| 2023 | 94.0% | +0.0% |
| 2024 | 93.0% | -1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 82.0% | 77.0% | 87.0% | 3 |
| 2000s | 94.1% | 90.0% | 95.0% | 10 |
| 2010s | 92.9% | 91.0% | 95.0% | 10 |
| 2020s | 94.2% | 93.0% | 95.0% | 5 |
Countries ranked near Australia
More health data for Australia
- Un projection of annual infant deaths, annual growth rate -1.83 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9072 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 906.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 215 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0283 units per person (2025)
- Population ages 05-09, male, annual growth rate -0.1776 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.03 units per person (2025)
- Population ages 10-14, female, annual growth rate 0.5871 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in Australia?
- Immunization, hib3 in Australia was 93.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Australia?
- The highest recorded value was 95.0% in 2001.
- What is the lowest immunization, hib3 recorded in Australia?
- The lowest recorded value was 77.0% in 1997.
- How does Australia rank for immunization, hib3?
- Australia ranks 78th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Australia?
- Over the last ten years it is up 2.2%. The long-run trend across the full record is rising.
- Where does this Australia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 28 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.